TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 84 filers reported holding TCR2 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,000 | -97.4% | 270 | -98.0% | 0.00% | – |
Q1 2022 | $38,000 | -40.6% | 13,763 | 0.0% | 0.00% | – |
Q4 2021 | $64,000 | -46.2% | 13,763 | -1.6% | 0.00% | – |
Q3 2021 | $119,000 | -73.8% | 13,980 | -49.6% | 0.00% | – |
Q2 2021 | $455,000 | -10.4% | 27,727 | +20.6% | 0.00% | -100.0% |
Q1 2021 | $508,000 | -28.6% | 22,993 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $711,000 | +133.1% | 22,993 | +53.4% | 0.00% | – |
Q3 2020 | $305,000 | +32.6% | 14,993 | 0.0% | 0.00% | – |
Q2 2020 | $230,000 | +132.3% | 14,993 | +17.1% | 0.00% | – |
Q1 2020 | $99,000 | -45.9% | 12,800 | 0.0% | 0.00% | – |
Q4 2019 | $183,000 | +90.6% | 12,800 | +100.0% | 0.00% | – |
Q3 2019 | $96,000 | -4.0% | 6,400 | -8.6% | 0.00% | – |
Q2 2019 | $100,000 | – | 7,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 4,050,865 | $11,748,000 | 4.96% |
MPM BioImpact LLC | 3,370,982 | $9,776,000 | 2.72% |
TANG CAPITAL MANAGEMENT LLC | 3,641,606 | $10,561,000 | 1.60% |
Newtyn Management, LLC | 692,799 | $2,009,000 | 0.38% |
K2 PRINCIPAL FUND, L.P. | 1,078,070 | $3,126,000 | 0.34% |
HARBOR CAPITAL ADVISORS, INC. | 64,341 | $187,000 | 0.14% |
Redmile Group, LLC | 1,094,645 | $3,174,000 | 0.12% |
Artal Group S.A. | 750,000 | $2,175,000 | 0.12% |
Oasis Management Co Ltd. | 200,000 | $580,000 | 0.10% |
X-Square Capital, LLC | 31,919 | $93,000 | 0.06% |